Pharmaceutical formulations of taxanes
US6040330A · kind A · utility
53Cited by
4References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 8, 1999 |
| Grant date | Mar 21, 2000 |
| Priority date | — |
| Expiry date | Jan 8, 2019 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A pharmaceutical formulation of a taxane antineoplastic agent, particularly paclitaxel or docetaxel or a pharmaceutically acceptable salt thereof, and N-methylpyrrolidin-2-one (NMP). The formulation may include other excipients and/or diluents, and is suitable for administration to patients with cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.